Nav1.4
Nav1.4 is a protein that in humans is encoded by the SCN4A gene. It is a voltage-gated sodium channel that plays a crucial role in the initiation and propagation of action potentials in skeletal muscle. Mutations in this gene have been associated with several myotonic disorders and periodic paralysis syndromes.
Structure[edit | edit source]
Nav1.4 is a large, complex protein composed of four homologous domains (I-IV), each containing six transmembrane segments (S1-S6). The S4 segment of each domain acts as the voltage sensor, while the pore-forming loop between S5 and S6 is responsible for sodium ion selectivity and conductance.
Function[edit | edit source]
Nav1.4 is primarily expressed in skeletal muscle, where it is responsible for the upstroke of the action potential. This rapid depolarization allows for the propagation of electrical signals along the muscle fiber, leading to muscle contraction.
Clinical significance[edit | edit source]
Mutations in the SCN4A gene can lead to a variety of neuromuscular disorders. These include Hyperkalemic periodic paralysis, Paramyotonia congenita, and Potassium-aggravated myotonia. These conditions are characterized by episodes of muscle weakness or stiffness, often triggered by exercise, cold, or potassium intake.
See also[edit | edit source]
References[edit | edit source]
```
This template is designed to categorize articles related to genes on human chromosome 17 as stubs, encouraging contributors to expand them. The `
` template is used to create a small stub box that will appear in the article. This box includes an image (in this case, `HumanChromosome17.png` should be an image relevant to human chromosome 17, if available), and a text indicating that the article is a stub about a gene on human chromosome 17, with a link to a relevant category for easy navigation and organization.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD